Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Labcatal
Annemasse, Francelabcatal.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Labcatal is a French pharmaceutical laboratory specializing in oligotherapy, the therapeutic use of trace elements to regulate metabolic functions. Founded in 1940, the company is widely recognized for its flagship brand, Oligosol, which offers a range of minerals such as Zinc, Copper, Magnesium, and Manganese in gluconate form for sublingual administration. Labcatal focuses on addressing functional disorders in areas including nutrition, dermatology, and general internal medicine. In 2020, the company was acquired by EA Pharma, an international group focused on health and nutrition, which has since integrated Labcatal's portfolio into its broader wellness and pharmaceutical offerings.
- Therapeutic areas
- ImmunologyNeurologyDermatologyInfectious DiseasesGastroenterology
- Modalities
- Small moleculeTrace elementsOligotherapy
- Industry
- Biotech
Beyond the preview
Go deeper on Labcatal.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Labcatal.